UNIVERSITY OF MIAMI
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 25
- Registration Number
- NCT00448682
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer
- Conditions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 30
- Registration Number
- NCT00448552
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 25
- Registration Number
- NCT00449163
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 13
- Registration Number
- NCT00449137
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 12
- Registration Number
- NCT00448643
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 32
- Registration Number
- NCT00449020
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Ahmed Versus Baerveldt Comparison Study
- Conditions
- Interventions
- First Posted Date
- 2006-09-14
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 276
- Registration Number
- NCT00376363
- Locations
- 🇺🇸
University of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States
Safety Study to Evaluate the Effect of Lowering Body Temperature During Cochlear Implantation
- Conditions
- Interventions
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 19
- Registration Number
- NCT00375882
- Locations
- 🇺🇸
University of Miami, Miller School of Medicine, Ear Institute, Miami, Florida, United States
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
- Conditions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 40
- Registration Number
- NCT00373659
- Locations
- 🇺🇸
Bascom Palmer Eye Instiyute, Miami, Florida, United States
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2006-08-16
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 13
- Registration Number
- NCT00364689
- Locations
- 🇺🇸
Center For Liver Diseases - University of Miami, Miami, Florida, United States